Novabay Pharmaceuticals Inc. sell Lokrim
Start price
19.01.26
/
20%
€13.10
Target price
19.01.27
-
Performance (%)
-96.64%
End price
11.05.26
-
Summary
This prediction is currently being closed. The SELL prediction by Lokrim for Novabay Pharmaceuticals Inc. is performing very well with a performance of -96.64%. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novabay Pharmaceuticals Inc. | - | - |
| iShares Core DAX® | 1,77 % | 3,45 % |
| iShares Nasdaq 100 | -3,50 % | 1,61 % |
| iShares Nikkei 225® | -4,94 % | 4,22 % |
| iShares S&P 500 | 0,30 % | 2,58 % |
According to Lokrim what are the pros and cons of Novabay Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Business model of the past or high risk
Comments by Lokrim for this prediction
In the thread Novabay Pharmaceuticals Inc. diskutieren
Sell Novabay Pharmaceuticals Inc.
In the thread Trading Novabay Pharmaceuticals Inc.
Sell beendet

